Jeff White

机构：Anthem (United States)

发表论文 9 篇 · 总被引 287 次 · h-index 4

代表论文

• Multiple sclerosis patients—benefit-risk preferences: Serious adverse event risks versus treatment efficacy (2009 · Journal of Neurology · 被引 125)
• Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation (2017 · Journal of Managed Care & Specialty Pharmacy · 被引 120)
• Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis (2017 · Cardiovascular Diabetology · 被引 35)
• Abstract 2: Comparative Effectiveness and Safety of Anticoagulant Therapy With Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients With Nonvalvular Atrial Fibrillation (2016 · Circulation Cardiovascular Quality and Outcomes · 被引 7)
• Denuded iliac endothelium with long-term high-cholesterol-diet-induced vascular dysfunction and accelerated atherosclerosis as well as neointimal formations after BMS implantation (2012 · Cardiovascular revascularization medicine)
• The cost of liability. (2003 · PubMed)